Global Biosimilars Market Projected to Witness a Robust Growth and Reach $71.8 Billion by 2026 - Market Report (2020-2026) by Industry Experts, Inc
Monday 11 Jan 2021
Industry Experts, Inc. published the new 2021 version of its global market report on Biosimilars. The new version of the report entitled "Global Biosimilars Market – Products, Applications and Regulations" reveals that the global market for Biosimilars application in Oncology therapeutics is the largest in 2020 closely followed by Autoimmune Disorders.
Due to the COVID-19 Pandemic, telehealth and tele-detailing (also called remoter detailing or web calls) have set forth that allow a biosimilars companies' commercialization branch to have a wide range with less few reps. Also, the fluidity of the labor market is another new dynamic allowing for a greater diversity of commercialization build-out models. These new dynamics greatly change how companies should be building models of commercialization that also has vast implications for potential BD partnerships. The solution to 'build versus buy' is no longer driven by the size, scale, and cost of a sales force leading to outdated product P&L's. However, a hybrid solution that a partial build plus skilled, experienced contractors plus CSO for sales reps will be the optimal solution. This hybrid model could allow for greater biosimilar uptake and more efficient uptake.
Global market for Biosimilars is dominated by Oncology, estimated at US$5.4 billion (38.6% share) in 2020, which is anticipated to post the slowest CAGR of 29% between 2020 and 2026 and reach a projected US$24.8 billion by 2026.
The report reviews, analyzes and projects the Biosimilars market for the period 2017-2026 in terms of USD. The market for Biosimilar product types analyzed in this study comprises Monoclonal Antibodies, Erythropoietin, Granulocyte Colony-Stimulating Factor (G-CSF), Insulin and Other product types (including Interferons, Follitropins, Recombinant Proteins etc.). The report also encompasses the market analysis for Therapeutic Areas consisting Oncology, Autoimmune Disorders, Blood Disorders, Growth Hormone Deficiency and Other therapeutic areas (including Chronic Diseases, Infectious Diseases, Cardiovascular Disorders etc.).
Global Biosimilars market is segmented into four major geographic regions, for the purpose of this study, namely Europe, North America, Asia-Pacific and Rest of World. These regional markets further analyzed for 14 independent countries across Europe – Germany, the United Kingdom, France, Spain and Italy; North America – the United States, Canada and Mexico; Asia-Pacific – China, India, Japan and South Korea; and Rest of World – Brazil and Israel.
This 356 page Biosimilars global market report includes 223 charts (includes a data table and graphical representation for each table), supported with a meaningful and easy to understand graphical presentation, of the market. The statistical tables represent the data for the global market by geographic region, product type and major therapeutic/application area. This report includes the brief business profiles of 27 key global players and 36 major players across North America – 10; Europe – 10; Asia-Pacific – 14; and Rest of World – 2. The report also provides the listing of the companies engaged in research & development, manufacturing and supply of Biosimilars. The global list of companies covers addresses, contact numbers and the website addresses of 155 companies.
California, USA based Industry Experts, Inc. is a multi-industry focused market research provider.
For more details, please visit: https://industry-experts.com/verticals/biotechnology/global-biosimilars-market-products-applications-and-regulations